3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
17
Phase 3
4
Phase 1/2
4
Phase 1
2
Phase EARLY_PHASE1
1
Phase 4
1
Phase 2/3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
1
Colonic Neoplasms
1
Interventions
Oxaliplatin
7
Fluorouracil
6
Leucovorin
5
Bevacizumab
4
Watchful Waiting
3
Capecitabine
3
XELOX
2
Neoadjuvant Therapy
2
Irinotecan
2
Indocyanine Green
2
Chemotherapy, Adjuvant
2
Cetuximab
2
sulindac sulfone
1
pembrolizumab
1
encorafenib
1
dehydroftorafur
1
cyclopropapyrroloindole
1
Tranexamic Acid
1
Standard of Care
1
Sentinel Lymph Node Biopsy
1
Radiofrequency Ablation
1
Preoperative Exercise
1
Positron Emission Tomography Computed Tomography
1
Panitumumab
1
Observation
1
Mental Status and Dementia Tests
1
Magnetic Resonance Spectroscopy
1
Iohexol
1
In Situ Hybridization, Fluorescence
1
Immunohistochemistry
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Colonic Neoplasms
×
Panitumumab
×
Clear all
NCT00647530
2019-05-17
FOxTROT
University of Birmingham
Phase 2/3
Unknown
1,053 enrolled